Back to Search Start Over

Supplementary Data from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer

Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details